Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -9.71% away from its 52-week high, while its distance from the 52-week low is 86.47%. The stock’s price range during this period has varied between $9.35 and $19.31. The company, active in the Healthcare sector, saw a trading volume of around 3.66 million for the day, considerably lower average daily volume of 6.87 million observed over the last three months.
Teva- Pharmaceutical Industries Ltd. ADR’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $19.31 on 11/06/24, and the lowest price during that time was $9.35, recorded on 12/11/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly decline of -8.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 19.75B and boasts a workforce of 37226 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.60, with a change in price of +0.10. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 7,526,518 in trading volume during the last 100 days, posting a change of +0.58%.
How TEVA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 3.18. Similarly, the long-term debt-to-equity ratio is also 2.75.
TEVA Stock Stochastic Average
As of today, the raw stochastic average of Teva- Pharmaceutical Industries Ltd. ADR over the past 50 days is 38.92%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 38.92%. Additionally, the Stochastic %K and %D values for the company were 24.89% and 18.92%, respectively, over the past 20 days.
TEVA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price increase of 67.00%. However, over the past six months, we’ve seen a weaker performance of 4.84%. The price of TEVA leaped by -5.50% over the last 30 days. And in the last five days, it has surged by 4.46%.
